FMR CORP 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
FMR CORP | 8,363,529 3.040% |
-2,533,757 (-23.25%) |
Filing |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
FMR CORP | 10,897,286 5.231% |
10,897,286 (New Position) |
Filing |